Genomics company to analyze Framingham Heart data

Boston University founded Framingham Genomic Medicine (Boston, Mass.) to analyze data from the Framingham Heart Study, an ongoing epidemiological study being conducted by the university and the National Heart, Lung and Blood Institute. The Framingham Heart Study is designed to identify risk factors for the development of cardiovascular disease among 5,209 patients living in Framingham, Mass. in 1948 as well as 5,135 patients added in 1971, representing the offspring of the original cohort and their spouses. The study also has collected data relevant to diseases of aging including osteoporosis, arthritis, pulmonary disorders, neurological disorders, deafness and diabetes. ...